Titolo	Data di pubblicazione	Autore(i)
1	Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.	2012	Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C.
2	Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy	1989	Gianni AM; Bregni M; Siena S; Tarella C.
3	Trophoblast cell line conditioned medium for in vitro culture and antigenic characterization of acute myeloid leukemia clonogenic cells.	1987	Ferrero D; Pregno P; Tarella C; Ruscetti FW; Pileri A; Gallo E.
4	Treatment options in skeletal localizations of hairy cell leukemia: A systematic review on the role of radiation therapy	2007	FILIPPI AR; FRANCO P; MARINONE C; TARELLA C; RICARDI U
5	Too soon, too much	2011	Chiò A; Tarella C
6	The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy	2013	Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C.
7	The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermedia.	1979	Gallo E; Massaro P; Miniero R; David D; Tarella C.
8	The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.	2015	Bodini M; Ronchini C; Giacò L; Russo A; Melloni GE; Luzi L; Sardella D; Volorio S; Hasan SK; Ottone T; Lavorgna S; Lo-Coco F; Candoni A; Fanin R; Toffoletti E; Iacobucci I; Martinelli G; Cignetti A; Tarella C; Bernard L; Pelicci PG; Riva L.
9	The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation	2007	Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella
10	The aging effect of chemotherapy on cultured human mesenchymal stem cells	2011	Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C
11	Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.	1982	FERRERO D; C. TARELLA; GALLO E; RUSCETTI FW; BREITMAN TR
12	Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.	2013	Ruella M; Salmoiraghi S; Risso A; Carobbio A; Buttiglieri S; Spatola T; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A.
13	Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis?	2007	Alberto Rocci; Marco Ruella; Irene Ricca; Cristiana Carniti; Manuela Zanni; Chiara Lobetti Bodoni; Marco Ladetto; Daniele Caracciolo; Mario Boccadoro; Paolo Corradini; Corrado Tarella
14	Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia	2008	Davide Rossi; Chiara Lobetti Bodoni; Elisa Genuardi; Luigia Monitillo; Daniela Drandi; Clara Deambrogi; Michaela Cerri; Irene Ricca; Alberto Rocci; Simone Ferrero; Elisa Bernocco; Daniela Capello; Lorenzo De Paoli; Luciana Bergui; Michela Boi; Paola Omedè; Massimo Massaia; Corrado Tarella; Roberto Passera; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto
15	Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia	2009	D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto
16	Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia	2009	D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto
17	Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients	2005	Irene Ricca; Alberto Rocci; Daniela Drandi; Mara Compagno; Roberto Francese; Paola Omedè; Loredana Santo; Michela Rosace; Federica De Marco; Monica Astolfi; Chiara Lobetti Bodoni; Maria Dell’Aquila; Sonia Vallet; Luciana Bergui; Andrea Gallamini; Carlo Marinone; Mario Boccadoro; Corrado Tarella; Marco Ladetto
18	Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients	2007	RICCA I; ROCCI A; DRANDI D; FRANCESE R; COMPAGNO M; LOBETTI BODONI C; DE MARCO F; ASTOLFI M; MONITILLO L; VALLET S; CALVI R; FICARA F; OMEDE P; ROSATO R; GALLAMINI A; MARINONE C; BERGUI L; BOCCADORO M; TARELLA C; LADETTO M
19	Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders	2004	LADETTO M; COMPAGNO M; RICCA I; PAGANO M; ROCCI A; ASTOLFI M; DRANDI D; DI CELLE PF; DELL'AQUILA M; MANTOAN B; VALLET S; PAGLIANO G; DE MARCO F; FRANCESE R; SANTO L; CUTTICA A; MARINONE C; BOCCADORO M; TARELLA C.
20	Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines	2004	Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella